Correlation Between Spyre Therapeutics and Biocardia
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Biocardia, you can compare the effects of market volatilities on Spyre Therapeutics and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Biocardia.
Diversification Opportunities for Spyre Therapeutics and Biocardia
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Spyre and Biocardia is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Biocardia go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Biocardia
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 0.81 times more return on investment than Biocardia. However, Spyre Therapeutics is 1.23 times less risky than Biocardia. It trades about -0.05 of its potential returns per unit of risk. Biocardia is currently generating about -0.04 per unit of risk. If you would invest 2,816 in Spyre Therapeutics on September 24, 2024 and sell it today you would lose (457.00) from holding Spyre Therapeutics or give up 16.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Spyre Therapeutics vs. Biocardia
Performance |
Timeline |
Spyre Therapeutics |
Biocardia |
Spyre Therapeutics and Biocardia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spyre Therapeutics and Biocardia
The main advantage of trading using opposite Spyre Therapeutics and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.Spyre Therapeutics vs. AKITA Drilling | Spyre Therapeutics vs. Joint Stock | Spyre Therapeutics vs. Q2 Holdings | Spyre Therapeutics vs. Ultra Clean Holdings |
Biocardia vs. Aerovate Therapeutics | Biocardia vs. Rezolute | Biocardia vs. AN2 Therapeutics | Biocardia vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stocks Directory Find actively traded stocks across global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |